In the Fight for Our Genes, Could We Lose What Makes Us Human?
By Ziyaad Bhorat,
openDemocracy
| 08. 17. 2016
Untitled Document
In the last 70 years we’ve come a long way towards unraveling the building blocks of human life. The human genome has been identified, sequenced, mapped, decoded, and interfered with. We’ve used this knowledge to clone Dolly the sheep, discover breast cancer-causing genes and create stem cells from our own skin. And now we stand on an exciting precipice: perfecting technologies that allow us to edit our genes with precision.
But as we embark further on the gene revolution and allow corporations and governments to deconstruct human beings down to their most basic parts, we have to question whether we may lose not just some of those parts in the process but something much greater and more important—what it means to be truly human.
Let’s start with the technology. At the 2016 World Economic Forum in Davos, a panel called Humankind and the Machine brought together leading experts in technology, governance, and bioethics to discuss new technologies that are sure to have a major impact on humanity: artificial intelligence, cyber-security, genetics, and space colonization.
When questioned...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
